Pneumonia, Viral (drug therapy) And NotB. Sun
List of bibliographic references
Number of relevant bibliographic references: 23.Ident. | Authors (with country if any) | Title |
---|---|---|
000032 | X. Yuan [République populaire de Chine] ; J S Mu [République populaire de Chine] ; G X Mo [République populaire de Chine] ; X S Hu [République populaire de Chine] ; P. Yan [République populaire de Chine] ; L X Xie [République populaire de Chine] | [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy]. |
000048 | H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
000050 | Y N Liu [République populaire de Chine] | [Pharmacotherapeutic about the new coronavirus pneumonia]. |
000060 | M L Sun [République populaire de Chine] ; J M Yang [République populaire de Chine] ; Y P Sun [République populaire de Chine] ; G H Su [République populaire de Chine] | [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. |
000075 | J P Zhao ; Y. Hu ; R H Du ; Z S Chen ; Y. Jin ; M. Zhou ; J. Zhang ; J M Qu ; B. Cao | [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]. |
000077 | [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. | |
000090 | L. Zhou [République populaire de Chine] ; H G Liu | [Early detection and disease assessment of patients with novel coronavirus pneumonia]. |
000217 | David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
000220 | Robert L. Kruse [États-Unis] | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. |
000222 | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
000330 | Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
000402 | Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
000545 | Huan Liang [République populaire de Chine] ; Ganesh Acharya [Suède] | Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow? |
000564 | Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
000615 | Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
000661 | Deng-Hai Zhang [République populaire de Chine] ; Kun-Lun Wu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Sheng-Qiong Deng [République populaire de Chine] ; Bin Peng [République populaire de Chine] | In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. |
000825 | Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
000826 | Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi | Drug targets for corona virus: A systematic review |
000A07 | Clark D. Russell [Royaume-Uni] ; Jonathan E. Millar [Royaume-Uni] ; J Kenneth Baillie [Royaume-Uni] | Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. |
000A18 | Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. |
000A37 | Ewen Callaway ; David Cyranoski | China coronavirus: Six questions scientists are asking. |
000A58 | Jaegyun Lim [Corée du Sud] ; Seunghyun Jeon [Corée du Sud] ; Hyun-Young Shin [Corée du Sud] ; Moon Jung Kim [Corée du Sud] ; Yu Min Seong [Corée du Sud] ; Wang Jun Lee [Corée du Sud] ; Kang-Won Choe [Corée du Sud] ; Yu Min Kang [Corée du Sud] ; Baeckseung Lee [Corée du Sud] ; Sang-Joon Park [Corée du Sud] | Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR |
000B95 | Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
This area was generated with Dilib version V0.6.33. |